This scenario is common, because the standard B12 blood test doesnt tell us nearly as much as doctors think it does
Since NAC converts to cysteine, a key precursor to glutathione (a compound that the body needs to produce glutathione), in the liver taking both is a great way to really help cover all your bases
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
This retrograde signaling mechanismmitochondria communicating upstream to the nucleusis what Brnice Benayoun, a faculty member at USC Leonard Davis and co-author on the Reynolds et al
